Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products

被引:0
|
作者
Chi-Ming Tu
机构
[1] Food and Drug Administration,Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Office of Medication Error Prevention and Risk Management, Division of Medication Error Prevention and Analysis
来源
Therapeutic Innovation & Regulatory Science | 2019年 / 53卷
关键词
prescribing practice; proprietary name; OTC drug; drug name confusion; medication error;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:132 / 137
页数:5
相关论文
empty
未找到相关数据